Market capitalisation, EUR | 628.45 m |
EPS, EUR | -1.23 |
P/B ratio | 2.91 |
P/E ratio | - |
Dividend yield | 0.00% |
Revenue, EUR | 157.50 m |
Net income, EUR | -208.35 m |
Profit margin | -132.29% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
ARK Genomic Revolution UCITS ETF USD Accumulating | 4.25% | Equity World Health Care Innovation | 36 | 0.75% | 4 | - | A408AY | IE000O5M6XO1 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.08% | Equity United States Health Care Biotech | 214 | 0.35% | 32 | +19.86% | A2JDYM | IE00BDZVHG35 |
iShares Nasdaq US Biotechnology UCITS ETF | 0.08% | Equity United States Health Care Biotech | 214 | 0.35% | 440 | +20.83% | A2DWAW | IE00BYXG2H39 |
iShares Healthcare Innovation UCITS ETF | 0.08% | Equity World Health Care Social/Environmental Innovation | 195 | 0.40% | 989 | +17.54% | A2ANH2 | IE00BYZK4776 |
Xtrackers Russell 2000 UCITS ETF 1C | 0.02% | Equity United States Small Cap | 1,497 | 0.30% | 1,828 | +34.22% | A1XEJT | IE00BJZ2DD79 |
SPDR Russell 2000 US Small Cap UCITS ETF | 0.02% | Equity United States Small Cap | 1,802 | 0.30% | 4,042 | +34.20% | A1XFN1 | IE00BJ38QD84 |